Literature DB >> 18619574

The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: an in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms.

Marta Kot1, Władysława A Daniel.   

Abstract

The aim of the present study was to estimate the relative contribution of cytochrome P450 isoforms (P450s), including P450s of the CYP2C subfamily, to the metabolism of caffeine in human liver. The experiments were carried out in vitro using cDNA-expressed P450s, liver microsomes and specific P450 inhibitors. The obtained results show that (1) apart from the 3-N-demethylation of caffeine - a CYP1A2 marker reaction and the main oxidation pathway of caffeine in man - 1-N-demethylation is also specifically catalyzed by CYP1A2 (not reported previously); (2) 7-N-demethylation is catalyzed non-specifically, mainly by CYP1A2 and, to a smaller extent, by CYP2C8/9 and CYP3A4 (and not by CYP2E1, as suggested previously); (3) C-8-hydroxylation preferentially involves CYP1A2 and CYP3A4 and, to a smaller degree, CYP2C8/9 and CYP2E1 (and not only CYP3A, as suggested previously) at a concentration of 100 microM corresponding to the maximum therapeutic concentration in humans. At a higher caffeine concentration, the contribution of CYP1A2 to this reaction decreases in favour of CYP2C8/9. The obtained data show for the first time the contribution of CYP2C isoforms to the metabolism of caffeine in human liver and suggest that apart from 3-N-demethylation, 1-N-demethylation may also be used for testing CYP1A2 activity. Moreover, they indicate that the C-8-hydroxylation is not exclusively catalyzed by CYP3A4.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619574     DOI: 10.1016/j.bcp.2008.05.025

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  PharmGKB summary: caffeine pathway.

Authors:  Caroline F Thorn; Eleni Aklillu; Ellen M McDonagh; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-05       Impact factor: 2.089

2.  Caffeine induction of sulfotransferases in rat liver and intestine.

Authors:  Tianyan Zhou; Yue Chen; Chaoqun Huang; Guangping Chen
Journal:  J Appl Toxicol       Date:  2011-07-01       Impact factor: 3.446

3.  Metabolites Associated with Coffee Consumption and Incident Chronic Kidney Disease.

Authors:  William J He; Jingsha Chen; Alexander C Razavi; Emily A Hu; Morgan E Grams; Bing Yu; Chirag R Parikh; Eric Boerwinkle; Lydia Bazzano; Lu Qi; Tanika N Kelly; Josef Coresh; Casey M Rebholz
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-04       Impact factor: 8.237

Review 4.  Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for in vitro Human Cytochrome P450 Enzyme Induction.

Authors:  Miriam Naomi Jacobs; Barbara Kubickova; Eugene Boshoff
Journal:  Front Toxicol       Date:  2022-06-20

5.  Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer.

Authors:  Kristin A Guertin; Erikka Loftfield; Simina M Boca; Joshua N Sampson; Steven C Moore; Qian Xiao; Wen-Yi Huang; Xiaoqin Xiong; Neal D Freedman; Amanda J Cross; Rashmi Sinha
Journal:  Am J Clin Nutr       Date:  2015-03-11       Impact factor: 7.045

6.  Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.

Authors:  Tore Bjerregaard Stage; Magnus Graff; Susan Wong; Louise Ladebo Rasmussen; Flemming Nielsen; Anton Pottegård; Kim Brøsen; Deanna L Kroetz; S Cyrus Khojasteh; Per Damkier
Journal:  Br J Clin Pharmacol       Date:  2018-01-10       Impact factor: 4.335

Review 7.  Involvement of cytochrome P450 enzymes in inflammation and cancer: a review.

Authors:  Maria Carolina Stipp; Alexandra Acco
Journal:  Cancer Chemother Pharmacol       Date:  2020-10-28       Impact factor: 3.333

8.  Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine.

Authors:  Daniela Gordillo-Bastidas; Edén Oceguera-Contreras; Adriana Salazar-Montes; Jaime González-Cuevas; Luis Daniel Hernández-Ortega; Juan Armendáriz-Borunda
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

9.  Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption.

Authors:  Marilyn C Cornelis; Keri L Monda; Kai Yu; Nina Paynter; Elizabeth M Azzato; Siiri N Bennett; Sonja I Berndt; Eric Boerwinkle; Stephen Chanock; Nilanjan Chatterjee; David Couper; Gary Curhan; Gerardo Heiss; Frank B Hu; David J Hunter; Kevin Jacobs; Majken K Jensen; Peter Kraft; Maria Teresa Landi; Jennifer A Nettleton; Mark P Purdue; Preetha Rajaraman; Eric B Rimm; Lynda M Rose; Nathaniel Rothman; Debra Silverman; Rachael Stolzenberg-Solomon; Amy Subar; Meredith Yeager; Daniel I Chasman; Rob M van Dam; Neil E Caporaso
Journal:  PLoS Genet       Date:  2011-04-07       Impact factor: 5.917

Review 10.  Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.

Authors:  Enda M Byrne; Tõnu Esko; Michael A Nalls; Marilyn C Cornelis; Andrea Ganna; Nina Paynter; Keri L Monda; Najaf Amin; Krista Fischer; Frida Renstrom; Julius S Ngwa; Ville Huikari; Alana Cavadino; Ilja M Nolte; Alexander Teumer; Kai Yu; Pedro Marques-Vidal; Rajesh Rawal; Ani Manichaikul; Mary K Wojczynski; Jacqueline M Vink; Jing Hua Zhao; George Burlutsky; Jari Lahti; Vera Mikkilä; Rozenn N Lemaitre; Joel Eriksson; Solomon K Musani; Toshiko Tanaka; Frank Geller; Jian'an Luan; Jennie Hui; Reedik Mägi; Maria Dimitriou; Melissa E Garcia; Weang-Kee Ho; Margaret J Wright; Lynda M Rose; Patrik Ke Magnusson; Nancy L Pedersen; David Couper; Ben A Oostra; Albert Hofman; Mohammad Arfan Ikram; Henning W Tiemeier; Andre G Uitterlinden; Frank Ja van Rooij; Inês Barroso; Ingegerd Johansson; Luting Xue; Marika Kaakinen; Lili Milani; Chris Power; Harold Snieder; Ronald P Stolk; Sebastian E Baumeister; Reiner Biffar; Fangyi Gu; François Bastardot; Zoltán Kutalik; David R Jacobs; Nita G Forouhi; Evelin Mihailov; Lars Lind; Cecilia Lindgren; Karl Michaëlsson; Andrew Morris; Majken Jensen; Kay-Tee Khaw; Robert N Luben; Jie Jin Wang; Satu Männistö; Mia-Maria Perälä; Mika Kähönen; Terho Lehtimäki; Jorma Viikari; Dariush Mozaffarian; Kenneth Mukamal; Bruce M Psaty; Angela Döring; Andrew C Heath; Grant W Montgomery; Norbert Dahmen; Teresa Carithers; Katherine L Tucker; Luigi Ferrucci; Heather A Boyd; Mads Melbye; Jorien L Treur; Dan Mellström; Jouke Jan Hottenga; Inga Prokopenko; Anke Tönjes; Panos Deloukas; Stavroula Kanoni; Mattias Lorentzon; Denise K Houston; Yongmei Liu; John Danesh; Asif Rasheed; Marc A Mason; Alan B Zonderman; Lude Franke; Bruce S Kristal; Juha Karjalainen; Danielle R Reed; Harm-Jan Westra; Michele K Evans; Danish Saleheen; Tamara B Harris; George Dedoussis; Gary Curhan; Michael Stumvoll; John Beilby; Louis R Pasquale; Bjarke Feenstra; Stefania Bandinelli; Jose M Ordovas; Andrew T Chan; Ulrike Peters; Claes Ohlsson; Christian Gieger; Nicholas G Martin; Melanie Waldenberger; David S Siscovick; Olli Raitakari; Johan G Eriksson; Paul Mitchell; David J Hunter; Peter Kraft; Eric B Rimm; Dorret I Boomsma; Ingrid B Borecki; Ruth Jf Loos; Nicholas J Wareham; Peter Vollenweider; Neil Caporaso; Hans Jörgen Grabe; Marian L Neuhouser; Bruce Hr Wolffenbuttel; Frank B Hu; Elina Hyppönen; Marjo-Riitta Järvelin; L Adrienne Cupples; Paul W Franks; Paul M Ridker; Cornelia M van Duijn; Gerardo Heiss; Andres Metspalu; Kari E North; Erik Ingelsson; Jennifer A Nettleton; Rob M van Dam; Daniel I Chasman
Journal:  Mol Psychiatry       Date:  2014-10-07       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.